Abstract：
OBJECTIVE: The EnPlace® device is a novel minimally invasive tool allowing transvaginal sacrospinous ligament (SSL) fixation of apical pelvic organ prolapse (POP). The study aimed to investigate the safety and short-term efficacy of the EnPlace® SSL fixation for significant apical POP repair.
METHODS: A retrospective cohort study of 123 consecutive patients (mean age 64.4 ± 11.1 years) with stage III or IV apical POP who underwent SSL fixation by the EnPlace® device. Safety and 6-month outcome results were analyzed and compared between 91 (74%) patients with uterine prolapse versus 32 (26%) patients with vaginal vault prolapse.
RESULTS: There were no intraoperative or early postoperative complications. The mean (± standard deviation) duration of surgery was 30 ± 6.9 min and mean blood loss was 30.5 ± 18.5 mL. The average position of point C by POP-Quantification measurements before surgery and at 6 months postoperatively was 4.5 ± 2.8 cm and -3.1 ± 3.3 cm, respectively. Of 91 patients with preoperative uterine prolapse, eight (8.8%) patients developed a recurrent uterine prolapse within 6 months postoperatively. Of 32 patients with preoperative vault prolapse, two patients (6.3%) had recurrent vault prolapse.
CONCLUSIONS: Short-term outcome results of EnPlace® SSL fixation suggest that it is a safe and effective minimally invasive transvaginal procedure for significant apical POP repair.
METHODS: A retrospective cohort study of 123 consecutive patients (mean age 64.4 ± 11.1 years) with stage III or IV apical POP who underwent SSL fixation by the EnPlace® device. Safety and 6-month outcome results were analyzed and compared between 91 (74%) patients with uterine prolapse versus 32 (26%) patients with vaginal vault prolapse.
RESULTS: There were no intraoperative or early postoperative complications. The mean (± standard deviation) duration of surgery was 30 ± 6.9 min and mean blood loss was 30.5 ± 18.5 mL. The average position of point C by POP-Quantification measurements before surgery and at 6 months postoperatively was 4.5 ± 2.8 cm and -3.1 ± 3.3 cm, respectively. Of 91 patients with preoperative uterine prolapse, eight (8.8%) patients developed a recurrent uterine prolapse within 6 months postoperatively. Of 32 patients with preoperative vault prolapse, two patients (6.3%) had recurrent vault prolapse.
CONCLUSIONS: Short-term outcome results of EnPlace® SSL fixation suggest that it is a safe and effective minimally invasive transvaginal procedure for significant apical POP repair.
摘要：
目的：EnPlace®装置是一种新颖的微创工具，可用于经阴道骶棘韧带（SSL）固定骨盆顶端器官脱垂（POP）。该研究旨在调查EnPlace®SSL固定用于显著根尖POP修复的安全性和短期疗效。
方法：一项回顾性队列研究，对123例III期或IV期心尖POP患者（平均年龄64.4±11.1岁）进行了EnPlace®装置SSL固定。分析并比较了91例（74％）子宫脱垂患者与32例（26％）阴道穹窿脱垂患者的安全性和6个月预后结果。
结果：没有术中或术后早期并发症。手术的平均时间（±标准偏差）为30±6.9分钟，平均失血量为30.5±18.5mL。术前和术后6个月POP定量测量C点的平均位置为4.5±2.8cm和-3.1±3.3cm，分别。91例术前子宫脱垂,8例(8.8%)患者在术后6个月内出现复发性子宫脱垂。32例术前穹窿脱垂,两名患者(6.3%)复发性穹窿脱垂。
结论：EnPlace®SSL固定的短期结果结果表明，它是一种安全有效的经阴道微创手术，用于显著的根尖POP修复。
方法：一项回顾性队列研究，对123例III期或IV期心尖POP患者（平均年龄64.4±11.1岁）进行了EnPlace®装置SSL固定。分析并比较了91例（74％）子宫脱垂患者与32例（26％）阴道穹窿脱垂患者的安全性和6个月预后结果。
结果：没有术中或术后早期并发症。手术的平均时间（±标准偏差）为30±6.9分钟，平均失血量为30.5±18.5mL。术前和术后6个月POP定量测量C点的平均位置为4.5±2.8cm和-3.1±3.3cm，分别。91例术前子宫脱垂,8例(8.8%)患者在术后6个月内出现复发性子宫脱垂。32例术前穹窿脱垂,两名患者(6.3%)复发性穹窿脱垂。
结论：EnPlace®SSL固定的短期结果结果表明，它是一种安全有效的经阴道微创手术，用于显著的根尖POP修复。
